Automated Ion Channel Drug Discovery: Evaluation of hERG Inhibitors
Dr. Timm Danker, Application Specialist, Cytocentrics AG speaking at Screening Europe 2006.
Metabolomics as a Tool for Biomarker Discovery
Dr. Chris Beecher, Vice President of Biochemistry and Technology, Metabolon, Inc., speaking at Advances in Metabolic Profiling 2005
HTS/HCS in the Context of Genetic Toxicology
Dr. Richard Walmsley, University of Manchester and Gentronix Ltd. speaking at Screening Europe 2006.
Metabolic Profiles and Biomarkers for Detection and Prediction of Drug Effects
Hans Senn of F. Hoffmann-La Roche AG speaking at Advances in Metabolic Profiling 2005.
Predicting the Safety of FDA Regulated Products with Metabolomics
Laura Schnackenberg, Center for Metabolomics Research, speaks at Advances in Metabolic Profiling 2005.
HERG, Repolarization and Sudden Cardiac Death
Arthur M. Brown, Chairman and CEO, ChanTest, Inc., speaks at Ion Channel Targets 2005.
Extracellular Field Potential Recording in Cardiac Myocyte Culture with the QT-Screen System
Prof. Dr. Elke Guenther, Head of Electrophysiology, NMI Natural and Medical Sciences Institute, speaking at Screening Europe 2005.
hERG Screening: Ion Channel Cardiac Safety Pharmacology Using Whole-Cell Recordings in FlipTips
Dr. Martin Traebert, Group Head of in vitro Safety Pharmacology in Preclinical Development, Novartis Pharma AG, speaking at Screening Europe 2005.
|<< || 2 3 4 5 6 7 8 ||>>|
|Showing Results 71 - 78 of 78|